Coherent Ships 50 Millionth Thin Film Optical Filter

Coherent Ships 50 Millionth Thin Film Optical Filter GlobeNewswire September 10, 2025 SAXONBURG, Pa., Sept. 10, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, announces that its Advanced Coating Center in Santa Rosa, California, has shipped its 50 millionth thin-film filter, marking a major milestone in the company's 25-year history […]

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire September 10, 2025 DUBLIN, Sept. 10, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to five

LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions

LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions GlobeNewswire September 10, 2025 BOCA RATON, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has made an initial

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire September 10, 2025 ROCKAWAY, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Andy Brown has joined electroCore, effective September 9, 2025, as the Company's VP, Corporate Controller. The Compensation Committee

Superior Group of Companies to Participate in the Sidoti September Investor Conference

Superior Group of Companies to Participate in the Sidoti September Investor Conference GlobeNewswire September 10, 2025 ST. PETERSBURG, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman, President and Chief Executive Officer Michael Benstock and Chief Financial Officer Mike Koempel will participate in a fireside chat

Health Catalyst Appoints Ben Albert to the Role of President and COO

Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert has been appointed as President and Chief Operating Officer. https://mma.prnewswire.com/media/1323666/Health_Catalyst_Logo.jpg Albert served as the

Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma

(NASDAQ:RVMD), Long-term follow-up data for daraxonrasib monotherapy in second line metastatic pancreatic ductal adenocarcinoma reinforces promising clinical activity and durability Highly encouraging initial clinical results for daraxonrasib monotherapy and daraxonrasib plus chemotherapy in first line metastatic pancreatic ductal adenocarcinoma support planned initiation of three-arm Phase 3 trial in Q4 2025 Revolution Medicines to host webcast

Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma

Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma GlobeNewswire September 10, 2025 Long-term follow-up data for daraxonrasib monotherapy in second line metastatic pancreatic ductal adenocarcinoma reinforces promising clinical activity and durability Highly encouraging initial clinical results for

BRIXMOR PROPERTY GROUP ANNOUNCES THIRD QUARTER 2025 EARNINGS RELEASE AND TELECONFERENCE DATES

Brixmor Property Group Inc. (NYSE: BRX) today announced that it will release its 2025 third quarter earnings on Monday, October 27, 2025 after the market close. Brixmor will host a teleconference on Tuesday, October 28, 2025 at 10:00 AM ET. Event: Brixmor Property Group's Third Quarter Earnings Results When:10:00 AM ET, Tuesday, October 28, 2025

GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum on Wednesday, Sep. 24 at 8:00 a.m. ET. https://mma.prnewswire.com/media/2460831/Grail_Logo.jpg Live and replay webcasts may be accessed in

Scroll to Top